Meetup
Study AI424-034 was a randomised double-blind, multicenter trial comparing Reyataz (400 mg once daily) to efavirenz (600 mg once daily), each in combination with a fixed-dose combination of zidovudine (300 mg) and lamivudine (150 mg) given twice daily, in 810 antiretroviral treatment-naïve patients. ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.